188 related articles for article (PubMed ID: 17891187)
1. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation.
Bjorklund A; Aschan J; Labopin M; Remberger M; Ringden O; Winiarski J; Ljungman P
Bone Marrow Transplant; 2007 Dec; 40(11):1055-62. PubMed ID: 17891187
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
4. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.
Orasch C; Weisser M; Mertz D; Conen A; Heim D; Christen S; Gratwohl A; Battegay M; Widmer A; Flückiger U
Bone Marrow Transplant; 2010 Mar; 45(3):521-6. PubMed ID: 19668238
[TBL] [Abstract][Full Text] [Related]
5. Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation.
Martino R; Caballero MD; Canals C; San Miguel J; Sierra J; Rovira M; Solano C; Bargay J; Pérez-Simon J; León A; Sarrá J; Brunet S; de la Cámara R;
Bone Marrow Transplant; 2001 Aug; 28(4):341-7. PubMed ID: 11571505
[TBL] [Abstract][Full Text] [Related]
6. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
[TBL] [Abstract][Full Text] [Related]
7. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
8. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.
Forslöw U; Mattsson J; Ringden O; Klominek J; Remberger M
Scand J Infect Dis; 2006; 38(11-12):970-6. PubMed ID: 17148063
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
Du J; Liu J; Gu J; Zhu P
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
[TBL] [Abstract][Full Text] [Related]
10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.
Paris C; Kopp K; King A; Santolaya ME; Zepeda AJ; Palma J
Pediatr Blood Cancer; 2009 Sep; 53(3):453-8. PubMed ID: 19418548
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea.
Yoo JH; Lee DG; Choi SM; Choi JH; Park YH; Kim YJ; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Bone Marrow Transplant; 2004 Sep; 34(6):497-504. PubMed ID: 15286689
[TBL] [Abstract][Full Text] [Related]
14. Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC; Wright NB; Wong WB; Kristovich KM; Matthews EW; Weinberg KI; Amylon MD; Agarwal R
Pediatr Hematol Oncol; 2008 Dec; 25(8):705-22. PubMed ID: 19065437
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
[TBL] [Abstract][Full Text] [Related]
16. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
17. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.
Patriarca F; Skert C; Bonifazi F; Sperotto A; Fili C; Stanzani M; Zaja F; Cerno M; Geromin A; Bandini G; Baccarani M; Fanin R
Haematologica; 2006 Sep; 91(9):1268-72. PubMed ID: 16956831
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation.
Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR
Pediatr Hematol Oncol; 2005 Jun; 22(4):271-6. PubMed ID: 16020113
[TBL] [Abstract][Full Text] [Related]
19. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
[TBL] [Abstract][Full Text] [Related]
20. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
Xu LP; Zhang HY; Huang XJ; Liu KY; Liu DH; Han W; Chen H; Chen YH; Gao ZY; Zhang YC; Lu DP
Chin Med J (Engl); 2007 Oct; 120(19):1666-71. PubMed ID: 17935666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
